BR0010709A - Gonadotrofinas - Google Patents

Gonadotrofinas

Info

Publication number
BR0010709A
BR0010709A BR0010709-3A BR0010709A BR0010709A BR 0010709 A BR0010709 A BR 0010709A BR 0010709 A BR0010709 A BR 0010709A BR 0010709 A BR0010709 A BR 0010709A
Authority
BR
Brazil
Prior art keywords
gonadotropins
anovulatory women
folliculogenesis
induce
gonadotrofinas
Prior art date
Application number
BR0010709-3A
Other languages
English (en)
Other versions
BR0010709B1 (pt
Inventor
Stephen Franks
Stephen Hillier
Original Assignee
Applied Research Systems
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8241371&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR0010709(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Applied Research Systems filed Critical Applied Research Systems
Publication of BR0010709A publication Critical patent/BR0010709A/pt
Publication of BR0010709B1 publication Critical patent/BR0010709B1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/24—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

"GONADOTROFINAS". A presente invenção refere-se ao uso de gonadotrofinas na indução de foliculogênese em mulheres anovulatórias. Em particular, ela refere-se ao uso de LH ( ou uma dose equivalente de hCG ) na produção de um medicamento para a indução de foliculogênese em mulheres anovulatórias em doses diárias especificadas. Em certas concretizações, LH pode ser usado em combinação com FSH.
BRPI0010709-3A 1999-05-07 2000-05-05 uso de lh para a produção de um medicamento para induzir a paucifoliculogênese ou unifoliculogênese em mulheres anovulatórias. BR0010709B1 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP99303574 1999-05-07
PCT/GB2000/001745 WO2000067778A1 (en) 1999-05-07 2000-05-05 Gonadotrophins

Publications (2)

Publication Number Publication Date
BR0010709A true BR0010709A (pt) 2002-06-04
BR0010709B1 BR0010709B1 (pt) 2011-11-29

Family

ID=8241371

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0010709-3A BR0010709B1 (pt) 1999-05-07 2000-05-05 uso de lh para a produção de um medicamento para induzir a paucifoliculogênese ou unifoliculogênese em mulheres anovulatórias.

Country Status (18)

Country Link
US (2) US7695721B1 (pt)
EP (1) EP1176976B2 (pt)
JP (1) JP4975215B2 (pt)
CN (1) CN1352566A (pt)
AR (1) AR023869A1 (pt)
AT (1) ATE332705T1 (pt)
AU (1) AU4592800A (pt)
BR (1) BR0010709B1 (pt)
CA (1) CA2372714A1 (pt)
DE (1) DE60029318T3 (pt)
DK (1) DK1176976T4 (pt)
ES (1) ES2267531T5 (pt)
HK (1) HK1045261A1 (pt)
IL (2) IL146252A0 (pt)
PT (1) PT1176976E (pt)
SI (1) SI1176976T2 (pt)
TW (1) TWI242440B (pt)
WO (1) WO2000067778A1 (pt)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002324183B2 (en) * 2001-09-12 2007-10-25 Merck Serono Sa Use of hCG and LH in controlled ovarian hyperstimulation
BR0212429A (pt) * 2001-09-12 2004-10-26 Applied Research Systems Uso de hcg na hiperestimulação ovariana controlada
MEP38808A (en) * 2001-09-12 2011-02-10 Merck Serono Sa Use of lh in controlled ovarian hyperstimulation
US7402558B2 (en) 2001-09-12 2008-07-22 Laboratoires Seronosa Method for aiding implantation or decreasing miscarriage rate
CA2515297A1 (en) * 2003-02-07 2004-08-19 Ambros Valentin Huber Use of human chorionic gonadotropin in the treatment of symptoms caused by endometriosis
US20040248784A1 (en) * 2003-06-03 2004-12-09 Marco Filicori Unitary combinations of FSH and hCG
US7740884B2 (en) * 2003-06-20 2010-06-22 Ares Trading S.A. Freeze-dried FSH/LH formulations
TWI488640B (zh) 2008-04-16 2015-06-21 Ferring Int Ct Sa 藥學製劑
TWI604850B (zh) * 2009-10-05 2017-11-11 菲瑞茵國際中心股份有限公司 藥學製劑
WO2012016576A1 (en) 2010-08-04 2012-02-09 Glycotope Gmbh Improved recombinant human follicle-stimulating hormone
WO2012042381A1 (en) 2010-09-29 2012-04-05 Ferring B.V. Composition for controlled ovarian stimulation
WO2012127501A2 (en) * 2011-03-11 2012-09-27 Sanzyme Limited Composition for improving endometrial thickness during ovarian stimulation
US9353172B2 (en) 2011-07-18 2016-05-31 Arts Biologics A/S Long acting biologically active luteinizing hormone (LH) compound
WO2014013491A1 (en) * 2012-07-18 2014-01-23 Mor Research Applications Ltd. Intrauterine device
US11389133B2 (en) 2016-10-28 2022-07-19 Samsung Electronics Co., Ltd. Method and apparatus for follicular quantification in 3D ultrasound images
US11376220B2 (en) 2017-06-30 2022-07-05 Therio, LLC Single-injection methods and formulations to induce and control multiple ovarian follicles in bovine, caprine, ovine, camelid and other female animals
IT202000022015A1 (it) * 2020-09-18 2022-03-18 Marca Antonio La Nuovo uso dell'ormone luteinizzante

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1197570B (it) * 1983-02-11 1988-12-06 Serono Ist Farm Miscele di fsh e lh da ipofisi porcine in rapporto definito
US4845077A (en) * 1984-04-03 1989-07-04 Serono Laboratories, Inc. Method of inducing ovulation
US4725579A (en) 1985-02-21 1988-02-16 Serono Laboratories, Inc. Method of in vitro fertilization by a unique combination of gonadotropins
US5162306A (en) * 1987-01-23 1992-11-10 Donaldson Lloyd E Composition and method for producing superovulation in mammals
DK49987A (da) * 1987-01-30 1988-07-31 Nordisk Gentofte Fremgangsmaade til behandling af infertilitet og middel til anvendelse ved fremgangsmaaden
US5356876A (en) 1992-01-13 1994-10-18 Trinity University Methods of terminating pregnancy
JP2002531414A (ja) * 1998-12-01 2002-09-24 アクゾ・ノベル・エヌ・ベー 卵胞発生の改善

Also Published As

Publication number Publication date
IL146252A0 (en) 2002-07-25
JP4975215B2 (ja) 2012-07-11
CN1352566A (zh) 2002-06-05
SI1176976T2 (sl) 2015-12-31
HK1045261A1 (zh) 2002-11-22
DK1176976T4 (en) 2015-11-02
DE60029318T8 (de) 2007-11-22
ES2267531T5 (es) 2015-11-24
DE60029318T2 (de) 2007-08-09
US7151083B2 (en) 2006-12-19
DE60029318T3 (de) 2016-03-10
US7695721B1 (en) 2010-04-13
ES2267531T3 (es) 2007-03-16
PT1176976E (pt) 2006-11-30
TWI242440B (en) 2005-11-01
US20040224895A1 (en) 2004-11-11
DE60029318D1 (de) 2006-08-24
ATE332705T1 (de) 2006-08-15
CA2372714A1 (en) 2000-11-16
AU4592800A (en) 2000-11-21
IL146252A (en) 2010-06-30
EP1176976B1 (en) 2006-07-12
EP1176976B2 (en) 2015-10-21
DK1176976T3 (da) 2006-11-13
SI1176976T1 (sl) 2006-10-31
JP2002544168A (ja) 2002-12-24
WO2000067778A1 (en) 2000-11-16
AR023869A1 (es) 2002-09-04
BR0010709B1 (pt) 2011-11-29
EP1176976A1 (en) 2002-02-06

Similar Documents

Publication Publication Date Title
BR0010709A (pt) Gonadotrofinas
HK1077208A1 (en) Topical composition containing at least one vitminD or one vitamin D analogue and at least one cort icosteroid
BR9911408A (pt) Formas de dosagem contendo apomorfina paramelhora de disfunção erétil masculina
ITMI932122A1 (it) Chiodo endomidollare bloccato adatto in particolare per omero
BR0115067A (pt) Análogos de gnrh para tratamento de incontinência urinária
AP1893A (en) Compounds specific to adenosine A1, A2A and A3 receptor and uses thereof
IL124459A0 (en) Antagonists of gonadotropin releasing hormone
BRPI0304291B8 (pt) Absorvente higiênico.
BRPI0007487B8 (pt) difenil-uréias substituídas com w-carbóxi-arilas como inibidores de raf cinase
BR0209845A (pt) Formas de dosagem de oxcarbazepina e processo para a preparação das mesmas
BR0210013A (pt) Gel oftálmico de pirenzepina
BR0209206A (pt) Clatrato de hidrato de azitromicina com 1,2-propileno glicol, processo para a sua preparação e composição farmacêutica compreendendo o mesmo
BR0113148A (pt) Composições de 2-piridinamina e métodos relacionados
ITMI992107A0 (it) Uso del baclofen nel trattamento dell'astinenza da etanolo
MY117307A (en) New harmone medicaments and their use for correction of oestrogen deficiencies.
BRPI0012553B8 (pt) pastilha contendo cloridrato de ambroxol, seu processo de preparação e seu uso
BRPI0511305A (pt) método de aliviar um granuloma anular ou sarcóide, artigo manufaturado e uso de um antagonista de lfa-1
AR020832A1 (es) Procedimiento para la preparacion de una composicion de alta pureza de (7alfa, 17alfa)-17-hidroxi-7-metil-19-nor-17-pregn-5-(10)-en-20-in-3-ona
ES2190201T3 (es) Medicamento para la profilaxis y/o el tratamiento del carcinoma de mama que contiene un inhibidor esteroideo de la aromatasa.
CY1107227T1 (el) Θεραπεια αυτοανοσων νοσων με εκχυλισμα αμερικανικου γκινσενγκ
HUP0301831A2 (hu) Gepiron bioaktív metabolitjainak alkalmazása pszichológiai rendellenességek kezelésére
BR0107630A (pt) Composição
ES2170649B1 (es) Uso de la cdp-colina en el tratamiento de la abstinencia alcoholica.
BR0011049A (pt) Fenilciclohexanocarboxamidas substituìdas e seu uso como inibidores de absorção de adenosina
GR990100373A (el) Σταθερες συνθεσεις διαλυματων απομορφινης

Legal Events

Date Code Title Description
B25A Requested transfer of rights approved

Owner name: LABORATOIRES SERONO S.A. (CH)

Free format text: TRANSFERIDO DE: APPLIED RESEARCH SYSTEMS ARS HOLDING N.V.

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 29/11/2011, OBSERVADAS AS CONDICOES LEGAIS.

B25D Requested change of name of applicant approved
B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time
B24J Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)